The Department of Health and Human Services (HHS) has criticized the use of antipsychotics in nursing homes, where they are being abused on dementia patients masquerading as a treatment for schizophrenia[1][2]. According to a November 2022 HHS report, 99 nursing homes reported that 20% of their residents had schizophrenia, an increase of more than 200% since 2015, although the disease affects only 1% of the population[2]. Since 2011, the use of antipsychotics among long-term nursing home residents has fallen from 23.9% to 14.5% in 2021[1]. Overall, approximately 80% of Medicare residents were prescribed psychotropic medications from 2011 to 2019, with antipsychotics falling from 31% to 22%, but anticonvulsants rising from 28% to 40%[3][5]. Higher use of psychotropic medications is associated with homes with fewer registered nurses per capita and a higher proportion of low-income residents[3][5]. In the fourth quarter of 2019, approximately 20% of skilled nursing home residents, i.e. about 298,650 people per week, were receiving antipsychotics, mostly without a diagnosis of psychosis[6]. In January 2023, the Centers for Medicare and Medicaid Services (CMS) announced an investigation into the abuse of antipsychotics in nursing homes[2].